Today: 20 May 2026
Browse Category

ASX:CRD 11 November 2025

EME.L Soars on Duyung PSC Update: Empyrean Energy Jumps 90%+ as Conrad Asia Seeks Farm‑Down Completion (11 November 2025)

EME.L Soars on Duyung PSC Update: Empyrean Energy Jumps 90%+ as Conrad Asia Seeks Farm‑Down Completion (11 November 2025)

Empyrean Energy shares jumped as much as 96% in London on Tuesday after the company flagged a pending operator update at Indonesia’s Mako Gas Field. Trading volumes topped 2.2 billion shares, with Empyrean among the most-traded stocks on Interactive Investor. The surge followed news that operator Conrad Asia Energy halted its ASX-listed shares pending a farm-down announcement at the Duyung PSC, where Empyrean holds 8.5%.
11 November 2025
····

Stock Market Today

  • South Korea’s Kospi Surges Triple in 18 Months Outpacing Nasdaq Dotcom Gains
    May 19, 2026, 7:28 PM EDT. South Korea's Kospi index has surged threefold in 18 months, surpassing the Nasdaq's dotcom-era highs, driven by robust performances from tech giants Samsung Electronics and SK Hynix. The rally is fueled by ongoing artificial intelligence (AI) euphoria, as global demand for semiconductors and advanced technology stocks lifts investor sentiment. This growth highlights shifting investor focus towards South Korea's tech-driven market amid evolving AI landscapes, outperforming historical tech booms. Analysts note sustained demand and innovation are key to maintaining momentum, placing Kospi at the forefront of global stock market gains.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Go toTop